|
Session 16
Oral Abstracts
Implementing Antiretroviral Therapy in Developing Countries
Monday, 4 - 6 pm
Room: Ballroom 5-6 |
Moderators: |
Barbara Marston
CDC Kenya, Nairobi
|
| 4:00 pm 62 |
Adherence to NNRTI-based Regimens and Virologic Outcomes in HIV-infected South African Adults
Jean Nachega*1, M Hislop2, L Rengensberg2, R Chaisson3, and G Maartens4
1Johns Hopkins Univ, Baltimore, MD, US; 2AID For AIDS, Cape Town, South Africa; 3Johns Hopkins Univ, Sch of Med, Baltimore, MD, US; and 4Univ of Cape Town, South Africa |
| 4:15 pm 63 |
Mortality and Causes of Death in Adults Receiving HAART in Senegal: A 7-Year Cohort Study
J F Etard1,2, A Dieng2, A Diouf2, M Thierry-Mieg2, V Cilote2,3, B Taverne1,2, S Mboup4, I Ndoye5, Eric Delaporte*1, P Sow4, and ANRS 1290
1Inst for Res and Devt and Univ of Montpellier, France; 2Fann Hosp Regional Res and Training Ctr for HIV/AIDS, Dakar, Senegal; 3French Ministry of Foreign Affairs, Dakar, Senegal; 4Fann Hosp, Dakar, Senegal; and 5Multisectorial AIDS Prgm, Dakar, Senegal |
| 4:30 pm 64 |
Rapid Scale-up of Antiretroviral Services in Zambia: 1-year Clinical and Immunologic Outcomes
Moses Sinkala*1, J Levy2, I Zulu3, A Mwango1, E Stringer2, B Chi2, S Reid2, T Ellerbrock4, M Bulterys5, and J Stringer2
1Ministry of Hlth, Lusaka, Zambia; 2Univ of Alabama at Birmingham, Ctr for Infectious Disease Res, Lusaka, Zambia; 3Univ of Zambia Sch of Med; 4CDC, Atlanta, GA, US; and 5CDC, Lusaka, Zambia |
| 4:45 pm 65 |
Performance Characteristics of Non-CD4-based Criteria for Initiation of ART in an Ambulatory Clinic Population in Phnom Penh, Cambodia
Chel Sarim*1, J Elliott1, S Huffam1, H Chenda1, P Sophea1, S Vonthanak1, J Kaldor2, D Cooper2, and M Vun1
1Natl Ctr for HIV/AIDS, Dermatology and STI, Ministry of Hlth Cambodia, Phnom Penh and 2Natl Ctr in HIV Epidemiology and Clin Res, Univ of New South Wales, Sydney, Australia |
| 5:00 pm 66 |
Regimen Durability and Tolerability to 36-month Duration on ART in Khayelitsha, South Africa
Andrew Boulle*1, G Van Cutsem2, D Coetzee1, K Hilderbrand1,2, E Goemaere2, and G Maartens3
1Univ of Cape Town, Sch of Publ Hlth and Family Med, South Africa; 2Médecins Sans Frontières; and 3Univ of Cape Town, South Africa |
| 5:15 pm 67 |
When Are Adults in Resource-constrained Settings Most Likely to Experience an HIV-associated Illness following HAART Initiation and What Is It Related To?
Paula Braitstein*1, M Brinkhof1, M Schechter2,3, N Kumarasamy4, D Nash5, A Boulle6, E Ekong7, F Dabis8, E Balestre8, M Egger1, and the Antiretroviral Treatment in Lower Income Countries (ART-LINC) Collaboration
1Univ of Berne, Switzerland; 2Hosp Univ Clementino Fraga Filho, Rio de Janeiro, Brazil; 3Fed Univ of Rio de Janeiro, Brazil; 4YRG CARE, Chennai, India; 5Columbia Univ, Mailman Sch of Publ Hlth, New York, NY, US; 6Univ of Cape Town, Sch of Publ Hlth and Family Med, South Africa; 7Military Reference Hosp, Lagos, Nigeria; and 8INSERM 593, Univ Victor Segalen, Bordeaux, France |
| 5:30 pm 68 |
Tuberculosis among HIV-infected Patients Receiving HAART: Long-term Incidence and Risk Factors in a South African Cohort
Stephen Lawn*1,2, M Badri1, and R Wood1
1Desmond Tutu HIV Ctr, Univ of Cape Town, South Africa and 2London Sch of Hygiene and Tropical Med, UK |
| 5:45 pm 69 |
Prevalence of HIV and Undiagnosed Tuberculosis in a Peri-urban Community in South Africa
Linda-Gail Bekker*1, K Middelkoop1, L Myer2, A Whitelaw2, A Grant3, G Kaplan4, S Lawn1,3, and R Wood1
1Desmond Tutu HIV Ctr, Univ of Cape Town, South Africa; 2Univ of Cape Town, South Africa; 3London Sch of Hygiene and Tropical Med, UK; and 4Publ Hlth Inst, Newark, NJ, US |
|
